| DC Field | Value | Language |
|---|
| dc.contributor.author | Ganieva N. A., Djuraeva E. R., Qodirxo‘jaev I. O. | - |
| dc.date.accessioned | 2026-10-20T04:49:39Z | - |
| dc.date.available | 2026-10-20T04:49:39Z | - |
| dc.date.issued | 2026-01 | - |
| dc.identifier.issn | 2760-4942 | - |
| dc.identifier.uri | http://repo.tma.uz/xmlui/handle/1/5528 | - |
| dc.description.abstract | This article analyzes the effectiveness of long-term urate-lowering therapy (ULT)
and the problems of adherence in patients with gout. The current clinical and
social significance of gout, as well as its association with cardiovascular and renal
complications, is highlighted. Based on the analysis of scientific literature, the
key role of ULT in maintaining serum uric acid (SUA) levels within target ranges
is demonstrated. The article discusses patients’ adherence to urate-lowering
therapy, reasons for low adherence, and its impact on clinical outcomes.
Additionally, methods for assessing adherence, including subjective and
objective approaches, the importance of laboratory monitoring, and
comprehensive patient education strategies, are reviewed. In conclusion,
improving adherence to urate-lowering therapy is crucial for effective gout
management, reducing complications, and enhancing patients’ quality of life. | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | Eureka Journal of Health Sciences & Medical Innovation (EJHSMI) | en_US |
| dc.subject | Gout, urate-lowering therapy, serum uric acid, treatment adherence, urate-lowering drugs, long-term therapy, complications. | en_US |
| dc.title | ASSESSMENT OF LONG-TERM URATE-LOWERING THERAPY EFFECTIVENESS AND ADHERENCE IN PATIENTS WITH GOUT | en_US |
| dc.type | Article | en_US |
| Appears in Collections: |
|
